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The m.8344A > G mutation in the mt-tRNALys gene, first described in myoclonic epilepsy and ragged red fibers (MERRF), accounts
for approximately 80% of mutations in individuals with MERRF syndrome. Although originally described in families with a classical
syndrome of myoclonus, ataxia, epilepsy and ragged red fibers in muscle biopsy, the m.8344A > G mutation is increasingly
recognised to exhibit marked phenotypic heterogeneity. This paper describes the clinical, morphological and laboratory features of
an unusual phenotype in a patient harboring the m.8344A > G ‘MERRF’ mutation. We present the case of a middle-aged woman
with distal weakness since childhood who also had ptosis and facial weakness and who developed mid-life respiratory insufficiency
necessitating non-invasive nocturnal ventilator support. Neurophysiological and acetylcholine receptor antibody analyses excluded
myasthenia gravis whilst molecular genetic testing excluded myotonic dystrophy, prompting a diagnostic needle muscle biopsy.
Mitochondrial histochemical abnormalities including subsarcolemmal mitochondrial accumulation (ragged-red fibers) and in excess of
90% COX-deficient fibers, was seen leading to sequencing of the mitochondrial genome in muscle. This identified the m.8344A > G
mutation commonly associated with the MERRF phenotype. This case extends the evolving phenotypic spectrum of the
m.8344A > G mutation and emphasizes that it may cause indolent distal weakness with respiratory insufficiency, with marked
histochemical defects in muscle. Our findings support consideration of screening of this gene in cases of indolent myopathy
resembling distal limb-girdle muscular dystrophy in which screening of the common genes prove negative.
 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license (http://creativecommons.org/
licenses/by/3.0/).
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Myoclonic Epilepsy with Ragged-Red Fibers (MERRF)
is a rare disorder [1], characterized by myoclonic epilepsyhttp://dx.doi.org/10.1016/j.nmd.2014.03.011
0960-8966/ 2014 The Authors. Published by Elsevier B.V.
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NE2 4HH, UK. Tel.: +44 1912827140; fax: +44 191 2824373.
E-mail address: grainne.gorman@ncl.ac.uk (G.S. Gorman).and cardinal histological features of mitochondrial
dysfunction [2], frequently caused by the m.8344A > G
mt-tRNALys (MTTK) gene mutation [3]. Although the
major features of MERRF include myoclonus, generalized
epilepsy, ataxia and ragged red fibers in the muscle
biopsy [2,3], it is increasingly recognized that phenotypic
heterogeneity is common [4]. We describe a 42-year-old
woman who presented with indolent, predominantly distal
myopathy and respiratory insufficiency not previouslys.org/licenses/by/3.0/).
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significant evidence of mitochondrial histochemical
abnormalities which led to a diagnosis. This study was
approved and performed under the ethical guidelines issued
by our institution and complied with the declaration of
Helsinki.2. Patient and methods
2.1. Case report
A 42-year-old woman, born with congenital talipes
equinovarus presented with slowly progressive hand
weakness, reduced exercise tolerance since childhood and
increasing dyspnea on exertion, migraine and treated
hypothyroidism. Her mother had a cardiac pacemaker
and her sister had epilepsy, but no evidence of myopathy.
Her brother had ptosis, obstructive sleep apnea requiring
non-invasive nocturnal ventilatory support and died of a
pulmonary embolism aged 40 years. Examination showed
a stature of 1.58 m, ptosis, slowed pursuit eye movements
but no significant restriction, striking lower facial
weakness and distal limb weakness (MRC grade 4) with
relative sparing of proximal musculature, with retained
tendon reflexes and normal sensation (Fig. 1A).
Myotonia was not found. Creatine kinase level was
normal and plasma lactic acid was raised (3.0 mmol/L
normal <2.1). Nerve conduction studies and EMG,
including SFEMG were normal. MRI brain imaging was
not performed. Acetylcholine receptor antibody assay
was negative. Cardiologic workup was normal. Forced
vital capacity in the erect position was 2.0 L, and
reduced to 1.5 L in the supine position, suggestive ofFig. 1. (A) Clinical features include hair thinning, bilateral ptosis, and marke
and mild neck flexor and extension weakness. (B) Illustrates a severe mitochon
accumulation (ragged-red fibers) on the SDH reaction and in excess of 90%
histochemistry. (E) Sequencing of the mitochondrial genome identified the well
present at very high levels of heteroplasmy in the patient’s skeletal muscle (
pyrosequencing. (F) Analysis of samples from the patient’s clinically-unaffecte
sister (3% mutation load in blood; 4% mutation load in urine) confirmed lower
the mutation could not be detected in blood from her clinically-unaffected 14diaphragmatic weakness. Arterial blood gases on room
air showed an elevated paCO2 of 6.13 kPa (pH 7.39 and
PO2 10.83) indicating hypercapnia. Overnight oximetry
showed that she spent 38 min below 90% oxygen
saturation and 26 min below 88% oxygen saturation,
indicative of hypoventilation. Non-invasive nocturnal
ventilatory support was commenced. Molecular genetic
testing excluded myotonic dystrophy prompting a
diagnostic needle muscle biopsy.
2.2. Histopathology and molecular genetic studies
Standard histopathological analysis of muscle was
undertaken. Total genomic DNA was extracted from
blood, urinary epithelium and skeletal muscle using
standard procedures. Mitochondrial DNA rearrangements
were investigated in muscle by long-range PCR whilst
direct sequencing of the entire mitochondrial genome was
undertaken as previously described [5]. Amplified PCR
products were sequenced using BigDye Terminator v3.1
chemistries (Applied Biosystems) and compared to the
revised Cambridge reference sequence (GenBank Accession
number NC_012920.1). Quantification of m.8344A > G
mutation load by pyrosequencing [6], was performed
using mutation-specific primers (details available on
request).
3. Results
Muscle biopsy analysis showed remarkable
mitochondrial histochemical abnormalities characterized
by subsarcolemmal mitochondrial accumulation
(ragged-blue fibers) on the SDH reaction (Fig. 1B) and ind facial diplegia with prominent temporalis muscle wasting, jaw weakness
drial histochemical defect, characterized by subsarcolemmal mitochondrial
COX-deficient fibers following COX (C) and sequential COX-SDH (D)
-characterised m.8344A > GMTTK gene mutation which was shown to be
94% mutation load) but lower levels in blood and urine by quantitative
d mother (16% mutation load in blood; 18% mutation load in urine) and
levels of the m.8344A > G heteroplasmy and maternal transmission, whilst
year-old nephew.
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prompting genetic studies to investigate a likely
mitochondrial etiology. Long-range PCR across the
major mtDNA arc revealed no evidence of mtDNA
rearrangements, and a screen for the m.3243A > G
mutation was negative. Sequencing of the mitochondrial
genome in muscle identified the well-characterised
m.8344A > G mutation commonly associated with the
MERRF phenotype (Fig. 1E). Quantitative
pyrosequencing confirmed the m.8344A > G mutation to
be present at very high levels of heteroplasmy in the
patient’s skeletal muscle (94% mutation load) but lower
levels in blood (38%) and urine (37%) (Fig. 1F). Analysis
of samples from the patient’s clinically unaffected mother
(16% mutation load in blood; 18% mutation load in
urine) and sister (3% mutation load in blood; 4%
mutation load in urine) confirmed lower levels of
m.8344A > G heteroplasmy and maternal transmission,
whilst the mutation could not be detected in blood from
her clinically unaffected 14 year-old nephew.
Unfortunately, tissue samples were unavailable from her
deceased brother or maternal grandmother for
mutational analysis.4. Discussion
We report a 42-year-old woman with exceptional clinical
and histological features of the m.8344A > G mutation;
very high levels of the mutation were detected in skeletal
muscle, associated with ptosis, marked facial and distal
muscle weakness, respiratory insufficiency and severe
COX deficiency. To date, over 300 patients with
MERRF syndrome due to the m.8344A > G mutation
have been described [4], and more than 40 m.8344A > G
patients have been reviewed at our centre; none appear to
share this unusual clinical and histochemical phenotype.
Moreover, facial weakness is a relatively uncommon
muscle manifestation of mitochondrial disorders. The
marked mitochondrial histochemical abnormalities were
suggestive of a pathogenic mtDNA mutation, exhibiting
high mutation threshold. However, due to the severity of
the histochemical defect with in excess of 90%
COX-deficient fibers in the muscle biopsy, and with a
phenotype strongly suggestive of a limb girdle muscular
dystrophy initial genetic testing was directed to whole
mtDNA genome sequencing in preference to targeted
m.8344A > G mutation analysis. Biopsy findings,
combined with the conspicuous discrepancy in the
segregation of m.8344 > G mutation load between tissues,
we suggest, accounts for the myopathic phenotype
although potential cis-acting modifiers were not evaluated
[7].
In conclusion, this case emphasizes that the
m.8344A > G mutation can cause indolent distal
weakness with respiratory insufficiency, with marked
histochemical defects in muscle and extends the evolvingphenotypic spectrum attributable to the m.8344A > G
“MERRF” mutation.
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